The Kable

The Kable

Share this post

The Kable
The Kable
💊 Pfizer makes a big, big bet on Seagen and its ADC; Sanofi makes a much more modest bet on diabetes; Developed countries bet on exporting pollution
Copy link
Facebook
Email
Notes
More

💊 Pfizer makes a big, big bet on Seagen and its ADC; Sanofi makes a much more modest bet on diabetes; Developed countries bet on exporting pollution

#296 | India’s e-pharmacy laws under review; Space travel for heart tissue; Detecting active TB no longer an issue

Vinod's avatar
Ria's avatar
Vinod
and
Ria
Mar 14, 2023
∙ Paid

Share this post

The Kable
The Kable
💊 Pfizer makes a big, big bet on Seagen and its ADC; Sanofi makes a much more modest bet on diabetes; Developed countries bet on exporting pollution
Copy link
Facebook
Email
Notes
More
Share

Hello, and welcome back to The Kable, where we're still trying to process the sheer magnitude of Pfizer's gambit on Seagen. $43 billion for a company that hasn't turned a profit at last reckoning does seem excessive.

Elsewhere, the GHIT Fund has invested ¥260 million in two Japanese firms, Shionogi and Takeda, for developing new malaria drugs, in partnership with MMV.

New therapies for RSV have been mushrooming a bit lately. GlobalData says this might lead to drug-resistant RSV soon enough.

In the UK, junior doctors have taken up the strike call, kicking off a 3-day walkout yesterday.

In new developments, researchers have developed new tech to easily detect active TB, and a new way to screen virus proteins for antibiotic properties, and, if anyone is still interested, a new therapy for Covid.

And finally, in news that gladdens our heart endlessly, the first of BioNTech's modular vaccine factories has made landfall in Rwanda.

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More